Clinical Trial Update: A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 results for a combo of pevonedistat, venetoclax, and azacitidine in adults with acute myeloid leukemia who cannot receive intensive chemotherapy; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Pevonedistat (pevonedistat)
• Venetoclax (venetoclax)

Snippet

Sponsor: Takeda | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: COMPLETED | Results posted: 2023-09-18